Breaking News Instant updates and real-time market news.

NVS

Novartis

$83.78

-0.29 (-0.34%)

05:24
08/29/18
08/29
05:24
08/29/18
05:24

Alcon announces voluntary global market withdrawal of CyPass Micro-Stent

Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market. In addition, Alcon advises surgeons to immediately cease further implantation with the CyPass Micro-Stent and to return any unused devices to Alcon. This decision and corresponding recommendation is based on an analysis of five-year post-surgery data from the COMPASS-XT long-term safety study. The FDA approved the CyPass Micro-Stent in July 2016 for use in conjunction with cataract surgery in adult patients with mild-to-moderate primary open-angle glaucoma based on the results of the landmark two-year COMPASS study. The COMPASS study demonstrated a statistically significant reduction in intraocular pressure at two years post-surgery in subjects implanted with the CyPass Micro-Stent at the time of cataract surgery, as compared to subjects undergoing cataract surgery alone. At two years post-surgery, there was little difference in endothelial cell loss between the CyPass Micro-Stent and cataract surgery-only groups, and results were consistent with peer-review literature benchmarks of cataract-related endothelial cell loss. "We believe that withdrawing the CyPass Micro-Stent from the market is in patients' best interest and is the right thing to do," said Dr. Stephen Lane, Chief Medical Officer, Alcon. "Although we are removing the product from the market now out of an abundance of caution, we intend to partner with the FDA and other regulators to explore labeling changes that would support the reintroduction of the CyPass Micro-Stent in the future." This voluntary market withdrawal applies to all versions of the CyPass Micro-Stent. Alcon will be communicating directly with ophthalmic surgeons with recommendations for evaluating and managing those patients who have already received a CyPass Micro-Stent and instructions for returning unused devices.

  • 12

    Sep

NVS Novartis
$83.78

-0.29 (-0.34%)

08/07/18
STFL
08/07/18
INITIATION
Target $30
STFL
Buy
Alder Biopharmaceuticals initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price target, calling it an attractive, differentiated "pure play" within the migraine antiCGRP prevention market. While Matteis acknowledges it "won't be easy" for Alder to compete with Amgen (AMGN), Novartis (NVS), Eli Lilly (LLY) and Teva (TEVA), he believes the unique profile of eptinezumab remains underappreciated and may allow it to capture meaningful, above consensus share of a large, emerging drug category.
08/13/18
PIPR
08/13/18
NO CHANGE
PIPR
Overweight
Regeneron should be bought on 'largely meaningless' CRL, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond recommends buying shares of Regeneron Pharmaceuticals on weakness after the company received a Complete Response Letter from the FDA regarding Eylea's supplemental Biologics License Application for Q12W dosing in wet macular degeneration. The CRL is "largely meaningless" as this label expansion is almost entirely a defensive move by Regeneron to counter potential Q12W labeling by competitor Novartis' (NVS) RTH258, Raymond tells investors in a research note. The analyst has "reasonable confidence" that approval for this label will come within two months. He keeps an Overweight rating on shares of Regeneron.
08/16/18
08/16/18
DOWNGRADE

Hold
AstraZeneca downgraded to Hold following outperformance at Jefferies
As previously reported, Jefferies analyst Ian Hilliker downgraded AstraZeneca (AZN) to Hold from Buy citing valuation following the stock's outperformance since he upgraded it in March. Hilliker has raised his price target on AstraZeneca to 6,200p, but notes that this only leaves about 8% of further upside. Following results for the Q2 period, Hilliker said Novartis (NVS) remains his top European Pharmaceuticals pick, followed by Roche (RHHBY) and GlaxoSmithKline (GSK) in third place.
08/23/18
MSCO
08/23/18
NO CHANGE
Target $45
MSCO
Overweight
Pfizer price target raised to $45 from $43 at Morgan Stanley
Morgan Stanley analyst David Risinger maintained an Overweight rating on Pfizer (PFE) and raised his price target to $45 based upon a 5-year CAGR for revenue growth of 3% and EPS growth of 7%. In a research note to investors, Risinger says he believes the primary driver of major pharma stock performance in recent months is "defensive rotation." Additionally, he notes that political news has been "encouraging" as of late, with President Trump tweeting on July 19 "Thank you to Novartis (NVS) for not increasing your prices on prescription drugs. Likewise to Pfizer." Looking ahead, the analyst says to watch for U.S. pricing perception drivers in the coming months that could impact pharma stock performance, including potential additional HHS action on drug rebates, November election results and manufacturer communication and action on U.S. list prices by early January.

TODAY'S FREE FLY STORIES

SQM

SQM

$37.08

-0.99 (-2.60%)

21:36
04/22/19
04/22
21:36
04/22/19
21:36
Initiation
SQM initiated  »

SQM initiated with a Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NEE

NextEra Energy

$190.53

1.21 (0.64%)

, UTX

United Technologies

$136.99

-0.01 (-0.01%)

20:25
04/22/19
04/22
20:25
04/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NEE

NextEra Energy

$190.53

1.21 (0.64%)

UTX

United Technologies

$136.99

-0.01 (-0.01%)

KO

Coca-Cola

$47.38

-0.11 (-0.23%)

VZ

Verizon

$58.38

0.33 (0.57%)

PG

Procter & Gamble

$106.04

-0.01 (-0.01%)

LMT

Lockheed Martin

$315.24

0.94 (0.30%)

SHW

Sherwin-Williams

$451.83

-0.61 (-0.13%)

TWTR

Twitter

$34.39

-0.01 (-0.03%)

STT

State Street

$69.92

-0.02 (-0.03%)

CNC

Centene

$48.19

0.04 (0.08%)

FITB

Fifth Third

$27.54

0.02 (0.07%)

NUE

Nucor

$57.00

-0.49 (-0.85%)

DGX

Quest Diagnostics

$85.17

-0.55 (-0.64%)

HAS

Hasbro

$88.02

-0.72 (-0.81%)

HOG

Harley-Davidson

$39.71

-1.2 (-2.93%)

PII

Polaris Industries

$98.93

0.185 (0.19%)

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

GPK

Graphic Packaging

$12.98

0.035 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 02

    May

  • 02

    May

  • 02

    May

  • 04

    May

  • 07

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 23

    Jun

  • 13

    Nov

LOGC

LogicBio Therapeutics

$12.28

0.15 (1.24%)

20:16
04/22/19
04/22
20:16
04/22/19
20:16
Hot Stocks
LogicBio Therapeutics' methylmalonic acidemia treatment gets FDA orphan status »

The FDA has grated an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

RBB

RBB Bancorp

$19.18

-0.61 (-3.08%)

19:38
04/22/19
04/22
19:38
04/22/19
19:38
Earnings
RBB Bancorp reports Q1 EPS 51c, consensus 55c »

Reports Q1 NII $25.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 08

    May

BEN

Franklin Resources

$35.04

-0.27 (-0.76%)

19:09
04/22/19
04/22
19:09
04/22/19
19:09
Periodicals
Franklin Resources to reduce workforce by up to 5%, Bloomberg says »

Franklin Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

TSLA

Tesla

$262.90

-10.35 (-3.79%)

18:59
04/22/19
04/22
18:59
04/22/19
18:59
Periodicals
Consumer Reports: Tesla 'Autopilot' is no substitute for a human driver »

Consumer Reports states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

CMRE

Costamare

$5.65

-0.09 (-1.57%)

, WHR

Whirlpool

$139.39

0.35 (0.25%)

18:56
04/22/19
04/22
18:56
04/22/19
18:56
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

CMRE

Costamare

$5.65

-0.09 (-1.57%)

WHR

Whirlpool

$139.39

0.35 (0.25%)

CDNS

Cadence Design

$64.23

0.87 (1.37%)

BEDU

Bright Scholar

$11.38

-0.105 (-0.91%)

RRC

Range Resources

$9.83

0.07 (0.72%)

WAL

Western Alliance

$43.36

-0.89 (-2.01%)

ALDR

Alder Biopharmaceuticals

$12.77

0.1 (0.79%)

ROKU

Roku

$58.19

1.5 (2.65%)

VCYT

Veracyte

$23.04

0.02 (0.09%)

HARP

Harpoon Therapeutics

$11.35

-1.68 (-12.89%)

RMBS

Rambus

$11.80

-0.1 (-0.84%)

GRTS

Gritstone Oncology

$14.57

0.86 (6.27%)

GES

Guess

$16.66

-0.41 (-2.40%)

BHP

BHP Group

$55.14

0.19 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 22

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 04

    May

  • 08

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 22

    May

  • 22

    May

  • 05

    Jun

  • 25

    Apr

PCG

PG&E

$21.45

0.435 (2.07%)

18:52
04/22/19
04/22
18:52
04/22/19
18:52
Hot Stocks
PG&E submits updated financing proposal for safety, reliability investments »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:40
04/22/19
04/22
18:40
04/22/19
18:40
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

PCG

PG&E

$21.45

0.435 (2.07%)

18:39
04/22/19
04/22
18:39
04/22/19
18:39
Hot Stocks
PG&E names Fred Buckman to board, expands board to 15 directors »

PG&E Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$204.62

0.79 (0.39%)

18:36
04/22/19
04/22
18:36
04/22/19
18:36
Periodicals
Apple sued for $1B by teen claiming glitch in facial recognition software »

The report by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

GOOG

Alphabet

$1,248.96

11.74 (0.95%)

, GOOGL

Alphabet Class A

$1,253.94

12.01 (0.97%)

18:36
04/22/19
04/22
18:36
04/22/19
18:36
Periodicals
Google walkout organizers say company retaliated against them, Wired says »

Two employee activists at…

GOOG

Alphabet

$1,248.96

11.74 (0.95%)

GOOGL

Alphabet Class A

$1,253.94

12.01 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    Apr

  • 14

    May

  • 27

    Oct

CTRA

Contura Energy

$56.27

0.5 (0.90%)

18:16
04/22/19
04/22
18:16
04/22/19
18:16
Hot Stocks
Contura Energy announces departure of CEO Kevin Crutchfield »

Contura Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

BWEN

Broadwind Energy

$1.88

0.06 (3.30%)

18:04
04/22/19
04/22
18:04
04/22/19
18:04
Hot Stocks
Broadwind Energy announces $19.5M tower order »

Broadwind Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 26

    Apr

HLX

Helix Energy

$8.59

0.2 (2.38%)

18:04
04/22/19
04/22
18:04
04/22/19
18:04
Earnings
Helix Energy reports Q1 adjusted EPS 1c, consensus 0c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 15

    May

VBTX

Veritex

$25.92

-0.3 (-1.14%)

18:03
04/22/19
04/22
18:03
04/22/19
18:03
Earnings
Veritex reports Q1 diluted operating EPS 59c, consensus 55c »

Net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 21

    May

BCS

Barclays

$8.70

-0.05 (-0.57%)

18:00
04/22/19
04/22
18:00
04/22/19
18:00
Periodicals
Barclays planning to slash bonuses for investment bankers, FT says »

Barclays plans to crack…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    Jun

NVDA

Nvidia

$188.48

2.22 (1.19%)

, TSLA

Tesla

$262.90

-10.35 (-3.79%)

17:53
04/22/19
04/22
17:53
04/22/19
17:53
Periodicals
Nvidia calls Tesla claims on self-driving 'inaccurate', MarketWatch says »

Tesla (TSLA) claims that…

NVDA

Nvidia

$188.48

2.22 (1.19%)

TSLA

Tesla

$262.90

-10.35 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

  • 22

    May

  • 10

    Jun

EFSC

Enterprise Financial

$42.49

-1.4 (-3.19%)

17:47
04/22/19
04/22
17:47
04/22/19
17:47
Hot Stocks
Enterprise Financial board raised dividend to 15c per share »

The company's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

EFSC

Enterprise Financial

$42.49

-1.4 (-3.19%)

17:46
04/22/19
04/22
17:46
04/22/19
17:46
Earnings
Enterprise Financial reports Q1 EPS 67c, consensus 91c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

17:45
04/22/19
04/22
17:45
04/22/19
17:45
General news
U.S. tax refunds »

U.S. tax refunds are on…

BPRN

Bank of Princeton

$32.30

(0.00%)

17:43
04/22/19
04/22
17:43
04/22/19
17:43
Earnings
Bank of Princeton reports Q1 EPS 3c, may not compare to consensus 53c »

Reports Q1 NII $9.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

LENS

Presbia

$0.56

-0.0034 (-0.61%)

17:29
04/22/19
04/22
17:29
04/22/19
17:29
Hot Stocks
Presbia discloses staff reduction, search for investor or strategic partner »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$43.36

-0.89 (-2.01%)

17:23
04/22/19
04/22
17:23
04/22/19
17:23
Earnings
Western Alliance reports Q1 adjusted EPS $1.16, consensus $1.09 »

Reports Q1 NII $247.3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

FCF

First Commonwealth

$13.26

-0.22 (-1.63%)

, SAN

Banco Santander

$5.12

-0.015 (-0.29%)

17:21
04/22/19
04/22
17:21
04/22/19
17:21
Hot Stocks
First Commonwealth to acquire 14 branches from Santander »

First Commonwealth…

FCF

First Commonwealth

$13.26

-0.22 (-1.63%)

SAN

Banco Santander

$5.12

-0.015 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.